Newlink Genetics Cor (NLNK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NLNK | AMGN | VRTX | REGN | BMY |
| Company | Newlink Genetics Cor | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 8.9100 | 312.75 | 400.00 | 900.00 | N/A |
| High | 8.9982 | 312.75 | 400.00 | 943.77 | N/A |
| Low | 7.3809 | 312.75 | 400.00 | 891.30 | N/A |
| Last | 8.0100 | 312.75 | 400.00 | 937.61 | 43.70 |
| Change | -1.1700 | +34.36 | -0.16 | +34.13 | unch |
| % Change | -12.75% | +12.34% | -0.04% | +3.78% | unch |
| Volume | 62,855 | 241,381 | 519 | 1,066,900 | 19,072 |
| 20-Day Average Volume | 600,075 | 2,176,724 | 969,426 | 509,390 | 13,859,993 |
| Previous Close | 9.1800 | 278.39 | 400.16 | 903.48 | 43.70 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3300 | 272.34 | 398.38 | 909.16 | 47.46 |
| 20-Day Raw Stochastic | 7.85% | 100.00% | 56.40% | 83.62% | 6.67% |
| 20-Day Relative Strength | 33.99% | 72.59% | 46.24% | 54.16% | 28.64% |
| Weighted Alpha | -67.30 | +34.59 | +13.93 | +23.24 | -36.87 |
| Today's Opinion | 72% Sell | 24% Buy | 8% Buy | 48% Buy | 100% Sell |
| Previous Opinion | 56% Sell | 16% Sell | 8% Buy | 8% Buy | 88% Sell |
| Last Month's Opinion | 8% Sell | 24% Sell | 24% Buy | 56% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -26.45% since 03/11/20 | +15.84% since 04/26/24 | +0.63% since 04/26/24 | +5.27% since 04/25/24 | -2.14% since 04/26/24 |
| Low | 0.8200 on 03/18/20 | 268.99 on 04/29/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 1.1900 on 03/12/20 | 312.75 on 05/03/24 | 406.95 on 05/01/24 | 943.77 on 05/02/24 | 45.38 on 04/29/24 |
| 1-Month | |||||
| %Chg | -43.67% since 02/18/20 | +13.97% since 04/03/24 | -2.16% since 04/03/24 | -1.79% since 04/02/24 | -15.89% since 04/03/24 |
| Low | 0.8200 on 03/18/20 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 1.7100 on 02/21/20 | 312.75 on 05/03/24 | 412.64 on 04/04/24 | 962.20 on 04/04/24 | 52.08 on 04/04/24 |
| 3-Month | |||||
| %Chg | -44.03% since 12/18/19 | -3.23% since 02/02/24 | -5.81% since 02/02/24 | -0.80% since 02/02/24 | -9.90% since 02/02/24 |
| Low | 0.8200 on 03/18/20 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 3.6000 on 12/26/19 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -54.59% since 09/18/19 | +15.89% since 11/03/23 | +6.33% since 11/03/23 | +14.51% since 11/02/23 | -16.91% since 11/03/23 |
| Low | 0.8200 on 03/18/20 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 3.6000 on 12/26/19 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 33,222 | 149,321,728 | 103,424,960 | 102,913,952 | 88,584,272 |
| Shares Outstanding, K | 37,328 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 940,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -42,990,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 430,000 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -8,270,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 1.17 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.20 on 02/05/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/13/20 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.87 | 29.92 | 24.04 | 42.10 |